Global Particle Therapy Market – Industry Analysis and Forecast (2019-2026) – By Type, By Product & Service, By System, By Cancer Type, By Application, and Region.

Global Particle Therapy Market was valued US$ 945.91 Mn in 2019 and is expected to reach US$ XX Mn by 2026, at a CAGR of XX% during a forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. To know about the Research Methodology:-Request Free Sample Report The major driving factor of particle therapy market is the growing global prevalence of cancer, growing adoption of particle therapy in clinical trials, advantages offered by particle therapy over photon therapy, and the increasing number of particle therapy centers worldwide. Furthermore, favorable government initiatives that are creating awareness and promoting the adoption of proton therapy among key end users are some of the other major factors driving the growth of the particle therapy market. Particle therapy is costly may hamper the market growth. The particle therapy market is majorly segmented into type, product & service, system, cancer type, application, and region. Particle therapy market based on type includes proton therapy, and heavy ion therapy. Particle therapy market in terms of product & service is classified into cyclotrons, synchrotrons, synchrocyclotrons, and others. Based on the particle therapy market, system segment is divided into multi-room systems, and single-room systems. In terms of cancer type segment particle therapy market is categorized into pediatric & prostate cancer, breast cancer, lung cancer, head & neck cancer, and other cancers. Further, particle therapy market based on application includes treatment applications, and research applications. In terms of product & services, synchrotron segment is expected to grow at the XX % rate during the forecast period, due to the increasing number of research activities as well as the increasing investments in the development of synchrotron facilities. Based on the type, proton therapy is expected to be the largest contributor to the particle therapy market, due to the high degree of precision, shorter treatment time, and reduced side-effects associated with proton therapy as compared to conventional photon therapies using X-rays. On the basic of application, treatment applications are expected to be the XX % of market share contributor to the particle therapy market, due to the growing number of cancer patients globally, increasing government initiatives such as aimed at equipping or upgrading hospitals with newer and advanced radiotherapy systems, and the increasing availability of funding for the adoption of advanced cancer treatment technologies. By region, The Asia Pacific region is expected to offer significant growth opportunities for players operating in the particle therapy market owing to the increasing healthcare expenditure and growth initiatives to promote the use of advanced particle therapy technologies in Asia Pacific countries. Key players operating in the global particle therapy market are Advanced Oncotherapy PLC., Danfysik A/S, Hitachi, Ltd., Ion Beam Applications SA, Mevion Medical Systems, Inc., and Optivus Proton Therapy, Inc., Protom International, Inc., Provision Healthcare, LLC, Sumitomo Heavy Industries, Ltd., and Varian Medical Systems, Inc. The objective of the report is to present comprehensive analysis of Global Particle Therapy Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Particle Therapy Market dynamics, structure by analyzing the market segments, and project the Global Particle Therapy Market size. Clear representation of competitive analysis of key players by Global Particle Therapy Market Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Particle Therapy Market (ASRS) make the report investor’s guide.

Scope of Global Particle Therapy Market: Inquire before buying

Global Particle Therapy Market, by Type:

• Proton Therapy • Heavy Ion Therapy

Global Particle Therapy Market, by Product & Service:

• Cyclotrons • Synchrotrons • Synchrocyclotrons • Others

Global Particle Therapy Market, by System:

• Multi-room Systems • Single-room Systems

Global Particle Therapy Market by Cancer Type:

• Pediatric & Prostate Cancer • Breast Cancer • Lung Cancer • Head & Neck Cancer • Other Cancers

Global Particle Therapy Market by Application:

• Treatment Applications • Research Applications

Global Particle Therapy Market, by Region:

• North America • Europe • Middle East & Africa • Asia Pacific • Latin America

Key players operating in Global Particle Therapy Market:

• Advanced Oncotherapy PLC. • Danfysik A/S • Hitachi, Ltd. • Ion Beam Applications Sa • Mevion Medical Systems, Inc. • Optivus Proton Therapy, Inc. • Protom International, Inc. • Provision Healthcare, LLC • Sumitomo Heavy Industries, Ltd. • Varian Medical Systems, Inc. • IBA Worldwide • Accuray Incorporated • Brainlab • Elekta AB • Panacea • Shinva Medical Instrument Co. Ltd • Xstrahl • Danfysik A/S • SAH Global LLC • Mitsubishi Electric Corporation • Koninklijke Philips N.V. • PTW Freiburg GmbH

Global Particle Therapy Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. Global Particle Therapy Market Size, by Market Value (US$ MN) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 4.4. Global Particle Therapy Market Industry Trends 5. Global Particle Therapy Market Analysis and Forecast 5.1. Global Particle Therapy Market Analysis and Forecast 5.2. Global Particle Therapy Market Size & Y-o-Y Growth Analysis 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa 5.2.5. Latin America 6. Global Particle Therapy Market Analysis and Forecast, by Type 6.1. Introduction and Definition 6.2. Key Findings 6.3. Global Particle Therapy Market Value Share Analysis, by Type 6.4. Global Particle Therapy Market Size (US$ Mn) Forecast, by Type 6.5. Global Particle Therapy Market Analysis, by Type 6.6. Global Particle Therapy Market Attractiveness Analysis, by Type 7. Global Particle Therapy Market Analysis and Forecast, by Product & Services 7.1. Introduction and Definition 7.2. Global Particle Therapy Market Value Share Analysis, by Product & Services 7.3. Global Particle Therapy Market Size (US$ Mn) Forecast, by Product & Services 7.4. Global Particle Therapy Market Analysis, by Product & Services 7.5. Global Particle Therapy Market Attractiveness Analysis, by Product & Services 8. Global Particle Therapy Market Analysis and Forecast, by System 8.1. Introduction and Definition 8.2. Global Particle Therapy Market Value Share Analysis, by System 8.3. Global Particle Therapy Market Size (US$ Mn) Forecast, by System 8.4. Global Particle Therapy Market Analysis, by System 8.5. Global Particle Therapy Market Attractiveness Analysis, by System 9. Global Particle Therapy Market Analysis and Forecast, by Cancer Type 9.1. Introduction and Definition 9.2. Global Particle Therapy Market Value Share Analysis, by Cancer Type 9.3. Global Particle Therapy Market Size (US$ Mn) Forecast, by Cancer Type 9.4. Global Particle Therapy Market Analysis, by Cancer Type 9.5. Global Particle Therapy Market Attractiveness Analysis, by Cancer Type 10. Global Particle Therapy Market Analysis and Forecast, by Application 10.1. Introduction and Definition 10.2. Global Particle Therapy Market Value Share Analysis, by Application 10.3. Global Particle Therapy Market Size (US$ Mn) Forecast, by Application 10.4. Global Particle Therapy Market Analysis, by Application 10.5. Global Particle Therapy Market Attractiveness Analysis, by Application 11. Global Particle Therapy Market Analysis, by Region 11.1. Global Particle Therapy Market Value Share Analysis, by Region 11.2. Global Particle Therapy Market Size (US$ Mn) Forecast, by Region 11.3. Global Particle Therapy Market Attractiveness Analysis, by Region 12. North America Particle Therapy Market Analysis 12.1. Key Findings 12.2. North America Particle Therapy Market Overview 12.3. North America Particle Therapy Market Value Share Analysis, by Type 12.4. North America Particle Therapy Market Forecast, by Type 12.4.1. Proton Therapy 12.4.2. Heavy Ion Therapy 12.5. North America Particle Therapy Market Value Share Analysis, by Product & Services 12.6. North America Particle Therapy Market Forecast, by Product & Services 12.6.1. Cyclotrons 12.6.2. Synchrotrons 12.6.3. Synchrocyclotrons 12.6.4. Others 12.7. North America Particle Therapy Market Value Share Analysis, by System 12.8. North America Particle Therapy Market Forecast, by System 12.8.1. Multi-room Systems 12.8.2. Single-room Systems 12.9. North America Particle Therapy Market Value Share Analysis, by Cancer Type 12.10. North America Particle Therapy Market Forecast, by Cancer Type 12.10.1. Pediatric & Prostate Cancer 12.10.2. Breast Cancer 12.10.3. Lung Cancer 12.10.4. Head & Neck Cancer 12.10.5. Others 12.11. North America Particle Therapy Market Value Share Analysis, by Application 12.12. North America Particle Therapy Market Forecast, by Application 12.12.1. Treatment Applications 12.12.2. Research Applications 12.13. North America Particle Therapy Market Value Share Analysis, by Country 12.14. North America Particle Therapy Market Forecast, by Country 12.14.1. U.S. 12.14.2. Canada 12.15. North America Particle Therapy Market Analysis, by Country 12.16. U.S. Particle Therapy Market Forecast, by Type 12.16.1. Proton Therapy 12.16.2. Heavy Ion Therapy 12.17. U.S. Particle Therapy Market Forecast, by Product & Services 12.17.1. Cyclotrons 12.17.2. Synchrotrons 12.17.3. Synchrocyclotrons 12.17.4. Others 12.18. U.S. Particle Therapy Market Forecast, by System 12.18.1. Multi-room Systems 12.18.2. Single-room Systems 12.19. U.S. Particle Therapy Market Forecast, by Cancer Type 12.19.1. Pediatric & Prostate Cancer 12.19.2. Breast Cancer 12.19.3. Lung Cancer 12.19.4. Head & Neck Cancer 12.19.5. Others 12.20. U.S. Particle Therapy Market Forecast, by Application 12.20.1. Treatment Applications 12.20.2. Research Applications 12.21. Canada Particle Therapy Market Forecast, by Type 12.21.1. Proton Therapy 12.21.2. Heavy Ion Therapy 12.22. Canada Particle Therapy Market Forecast, by Product & Services 12.22.1. Cyclotrons 12.22.2. Synchrotrons 12.22.3. Synchrocyclotrons 12.22.4. Others 12.23. Canada Particle Therapy Market Forecast, by System 12.23.1. Multi-room Systems 12.23.2. Single-room Systems 12.24. Canada Particle Therapy Market Forecast, by Cancer Type 12.24.1. Pediatric & Prostate Cancer 12.24.2. Breast Cancer 12.24.3. Lung Cancer 12.24.4. Head & Neck Cancer 12.24.5. Others 12.25. Canada Particle Therapy Market Forecast, by Application 12.25.1. Treatment Applications 12.25.2. Research Applications 12.26. North America Particle Therapy Market Attractiveness Analysis 12.26.1. By Type 12.26.2. By Product & Services 12.26.3. By System 12.26.4. By Cancer Type 12.26.5. By Application 12.27. PEST Analysis 13. Europe Particle Therapy Market Analysis 13.1. Key Findings 13.2. Europe Particle Therapy Market Overview 13.3. Europe Particle Therapy Market Value Share Analysis, by Type 13.4. Europe Particle Therapy Market Forecast, by Type 13.4.1. Proton Therapy 13.4.2. Heavy Ion Therapy 13.5. Europe Particle Therapy Market Value Share Analysis, by Product & Services 13.6. Europe Particle Therapy Market Forecast, by Product & Services 13.6.1. Cyclotrons 13.6.2. Synchrotrons 13.6.3. Synchrocyclotrons 13.6.4. Others 13.7. Europe Particle Therapy Market Value Share Analysis, by System 13.8. Europe Particle Therapy Market Forecast, by System 13.8.1. Multi-room Systems 13.8.2. Single-room Systems 13.9. Europe Particle Therapy Market Value Share Analysis, by Cancer Type 13.10. Europe Particle Therapy Market Forecast, by Cancer Type 13.10.1. Pediatric & Prostate Cancer 13.10.2. Breast Cancer 13.10.3. Lung Cancer 13.10.4. Head & Neck Cancer 13.10.5. Others 13.11. Europe Particle Therapy Market Value Share Analysis, by Application 13.12. Europe Particle Therapy Market Forecast, by Application 13.12.1. Treatment Applications 13.12.2. Research Applications 13.13. Europe Particle Therapy Market Value Share Analysis, by Country 13.14. Europe Particle Therapy Market Forecast, by Country 13.14.1. Germany 13.14.2. U.K. 13.14.3. France 13.14.4. Italy 13.14.5. Spain 13.14.6. Rest of Europe 13.15. Europe Particle Therapy Market Analysis, by Country/ Sub-region 13.16. Germany Particle Therapy Market Forecast, by Type 13.16.1. Proton Therapy 13.16.2. Heavy Ion Therapy 13.17. Germany Particle Therapy Market Forecast, by Product & Services 13.17.1. Cyclotrons 13.17.2. Synchrotrons 13.17.3. Synchrocyclotrons 13.17.4. Others 13.18. Germany Particle Therapy Market Forecast, by System 13.18.1. Multi-room Systems 13.18.2. Single-room Systems 13.19. Germany Particle Therapy Market Forecast, by Cancer Type 13.19.1. Pediatric & Prostate Cancer 13.19.2. Breast Cancer 13.19.3. Lung Cancer 13.19.4. Head & Neck Cancer 13.19.5. Others 13.20. Germany Particle Therapy Market Forecast, by Application 13.20.1. Treatment Applications 13.20.2. Research Applications 13.21. U.K. Particle Therapy Market Forecast, by Type 13.21.1. Proton Therapy 13.21.2. Heavy Ion Therapy 13.22. U.K. Particle Therapy Market Forecast, by Product & Services 13.22.1. Cyclotrons 13.22.2. Synchrotrons 13.22.3. Synchrocyclotrons 13.22.4. Others 13.23. U.K. Particle Therapy Market Forecast, by System 13.23.1. Multi-room Systems 13.23.2. Single-room Systems 13.24. U.K. Particle Therapy Market Forecast, by Cancer Type 13.24.1. Pediatric & Prostate Cancer 13.24.2. Breast Cancer 13.24.3. Lung Cancer 13.24.4. Head & Neck Cancer 13.24.5. Others 13.25. U.K. Particle Therapy Market Forecast, by Application 13.25.1. Treatment Applications 13.25.2. Research Applications 13.26. France Particle Therapy Market Forecast, by Type 13.26.1. Proton Therapy 13.26.2. Heavy Ion Therapy 13.27. France Particle Therapy Market Forecast, by Product & Services 13.27.1. Cyclotrons 13.27.2. Synchrotrons 13.27.3. Synchrocyclotrons 13.27.4. Others 13.28. France Particle Therapy Market Forecast, by System 13.28.1. Multi-room Systems 13.28.2. Single-room Systems 13.29. France Particle Therapy Market Forecast, by Cancer Type 13.29.1. Pediatric & Prostate Cancer 13.29.2. Breast Cancer 13.29.3. Lung Cancer 13.29.4. Head & Neck Cancer 13.29.5. Others 13.30. France Particle Therapy Market Forecast, by Application 13.30.1. Treatment Applications 13.30.2. Research Applications 13.31. Italy Particle Therapy Market Forecast, by Type 13.31.1. Proton Therapy 13.31.2. Heavy Ion Therapy 13.32. Italy Particle Therapy Market Forecast, by Product & Services 13.32.1. Cyclotrons 13.32.2. Synchrotrons 13.32.3. Synchrocyclotrons 13.32.4. Others 13.33. Italy Particle Therapy Market Forecast, by System 13.33.1. Multi-room Systems 13.33.2. Single-room Systems 13.34. Italy Particle Therapy Market Forecast, by Cancer Type 13.34.1. Pediatric & Prostate Cancer 13.34.2. Breast Cancer 13.34.3. Lung Cancer 13.34.4. Head & Neck Cancer 13.34.5. Others 13.35. Italy Particle Therapy Market Forecast, by Application 13.35.1. Treatment Applications 13.35.2. Research Applications 13.36. Spain Particle Therapy Market Forecast, by Type 13.36.1. Proton Therapy 13.36.2. Heavy Ion Therapy 13.37. Spain Particle Therapy Market Forecast, by Product & Services 13.37.1. Cyclotrons 13.37.2. Synchrotrons 13.37.3. Synchrocyclotrons 13.37.4. Others 13.38. Spain Particle Therapy Market Forecast, by System 13.38.1. Multi-room Systems 13.38.2. Single-room Systems 13.39. Spain Particle Therapy Market Forecast, by Cancer Type 13.39.1. Pediatric & Prostate Cancer 13.39.2. Breast Cancer 13.39.3. Lung Cancer 13.39.4. Head & Neck Cancer 13.39.5. Others 13.40. Spain Particle Therapy Market Forecast, by Application 13.40.1. Treatment Applications 13.40.2. Research Applications 13.41. Rest of Europe Particle Therapy Market Forecast, by Type 13.41.1. Proton Therapy 13.41.2. Heavy Ion Therapy 13.42. Rest of Europe Particle Therapy Market Forecast, by Product & Services 13.42.1. Cyclotrons 13.42.2. Synchrotrons 13.42.3. Synchrocyclotrons 13.42.4. Others 13.43. Rest of Europe Particle Therapy Market Forecast, by System 13.43.1. Multi-room Systems 13.43.2. Single-room Systems 13.44. Rest of Europe Particle Therapy Market Forecast, by Cancer Type 13.44.1. Pediatric & Prostate Cancer 13.44.2. Breast Cancer 13.44.3. Lung Cancer 13.44.4. Head & Neck Cancer 13.44.5. Others 13.45. Rest of Europe Particle Therapy Market Forecast, by Application 13.45.1. Treatment Applications 13.45.2. Research Applications 13.46. Europe Particle Therapy Market Attractiveness Analysis 13.46.1. By Type 13.46.2. By Product & Services 13.46.3. By System 13.46.4. By Cancer Type 13.46.5. By Application 13.47. PEST Analysis 14. Asia Pacific Particle Therapy Market Analysis 14.1. Key Findings 14.2. Asia Pacific Particle Therapy Market Overview 14.3. Asia Pacific Particle Therapy Market Value Share Analysis, by Type 14.4. Asia Pacific Particle Therapy Market Forecast, by Type 14.4.1. Proton Therapy 14.4.2. Heavy Ion Therapy 14.5. Asia Pacific Particle Therapy Market Value Share Analysis, by Product & Services 14.6. Asia Pacific Particle Therapy Market Forecast, by Product & Services 14.6.1. Cyclotrons 14.6.2. Synchrotrons 14.6.3. Synchrocyclotrons 14.6.4. Others 14.7. Asia Pacific Particle Therapy Market Value Share Analysis, by System 14.8. Asia Pacific Particle Therapy Market Forecast, by System 14.8.1. Multi-room Systems 14.8.2. Single-room Systems 14.9. Asia Pacific Particle Therapy Market Value Share Analysis, by Cancer Type 14.10. Asia Pacific Particle Therapy Market Forecast, by Cancer Type 14.10.1. Pediatric & Prostate Cancer 14.10.2. Breast Cancer 14.10.3. Lung Cancer 14.10.4. Head & Neck Cancer 14.10.5. Others 14.11. Asia Pacific Particle Therapy Market Value Share Analysis, by Application 14.12. Asia Pacific Particle Therapy Market Forecast, by Application 14.12.1. Treatment Applications 14.12.2. Research Applications 14.13. Asia Pacific Particle Therapy Market Value Share Analysis, by Country 14.14. Asia Pacific Particle Therapy Market Forecast, by Country 14.14.1. China 14.14.2. India 14.14.3. Japan 14.14.4. ASEAN 14.14.5. Rest of Asia Pacific 14.15. Asia Pacific Particle Therapy Market Analysis, by Country/ Sub-region 14.16. China Particle Therapy Market Forecast, by Type 14.16.1. Proton Therapy 14.16.2. Heavy Ion Therapy 14.17. China Particle Therapy Market Forecast, by Product & Services 14.17.1. Cyclotrons 14.17.2. Synchrotrons 14.17.3. Synchrocyclotrons 14.17.4. Others 14.18. China Particle Therapy Market Forecast, by System 14.18.1. Multi-room Systems 14.18.2. Single-room Systems 14.19. China Particle Therapy Market Forecast, by Cancer Type 14.19.1. Pediatric & Prostate Cancer 14.19.2. Breast Cancer 14.19.3. Lung Cancer 14.19.4. Head & Neck Cancer 14.19.5. Others 14.20. China Particle Therapy Market Forecast, by Application 14.20.1. Treatment Applications 14.20.2. Research Applications 14.21. India Particle Therapy Market Forecast, by Type 14.21.1. Proton Therapy 14.21.2. Heavy Ion Therapy 14.22. India Particle Therapy Market Forecast, by Product & Services 14.22.1. Cyclotrons 14.22.2. Synchrotrons 14.22.3. Synchrocyclotrons 14.22.4. Others 14.23. India Particle Therapy Market Forecast, by System 14.23.1. Multi-room Systems 14.23.2. Single-room Systems 14.24. India Particle Therapy Market Forecast, by Cancer Type 14.24.1. Pediatric & Prostate Cancer 14.24.2. Breast Cancer 14.24.3. Lung Cancer 14.24.4. Head & Neck Cancer 14.24.5. Others 14.25. India Particle Therapy Market Forecast, by Application 14.25.1. Treatment Applications 14.25.2. Research Applications 14.26. Japan Particle Therapy Market Forecast, by Type 14.26.1. Proton Therapy 14.26.2. Heavy Ion Therapy 14.27. Japan Particle Therapy Market Forecast, by Product & Services 14.27.1. Cyclotrons 14.27.2. Synchrotrons 14.27.3. Synchrocyclotrons 14.27.4. Others 14.28. Japan Particle Therapy Market Forecast, by System 14.28.1. Multi-room Systems 14.28.2. Single-room Systems 14.29. Japan Particle Therapy Market Forecast, by Cancer Type 14.29.1. Pediatric & Prostate Cancer 14.29.2. Breast Cancer 14.29.3. Lung Cancer 14.29.4. Head & Neck Cancer 14.29.5. Others 14.30. Japan Particle Therapy Market Forecast, by Application 14.30.1. Treatment Applications 14.30.2. Research Applications 14.31. ASEAN Particle Therapy Market Forecast, by Type 14.31.1. Proton Therapy 14.31.2. Heavy Ion Therapy 14.32. ASEAN Particle Therapy Market Forecast, by Product & Services 14.32.1. Cyclotrons 14.32.2. Synchrotrons 14.32.3. Synchrocyclotrons 14.32.4. Others 14.33. ASEAN Particle Therapy Market Forecast, by System 14.33.1. Multi-room Systems 14.33.2. Single-room Systems 14.34. ASEAN Particle Therapy Market Forecast, by Cancer Type 14.34.1. Pediatric & Prostate Cancer 14.34.2. Breast Cancer 14.34.3. Lung Cancer 14.34.4. Head & Neck Cancer 14.34.5. Others 14.35. ASEAN Particle Therapy Market Forecast, by Application 14.35.1. Treatment Applications 14.35.2. Research Applications 14.36. Rest of Asia Pacific Particle Therapy Market Forecast, by Type 14.36.1. Proton Therapy 14.36.2. Heavy Ion Therapy 14.37. Rest of Asia Pacific Particle Therapy Market Forecast, by Product & Services 14.37.1. Cyclotrons 14.37.2. Synchrotrons 14.37.3. Synchrocyclotrons 14.37.4. Others 14.38. Rest of Asia Pacific Particle Therapy Market Forecast, by System 14.38.1. Multi-room Systems 14.38.2. Single-room Systems 14.39. Rest of Asia Pacific Particle Therapy Market Forecast, by Cancer Type 14.39.1. Pediatric & Prostate Cancer 14.39.2. Breast Cancer 14.39.3. Lung Cancer 14.39.4. Head & Neck Cancer 14.39.5. Others 14.40. Rest of Asia Pacific Particle Therapy Market Forecast, by Application 14.40.1. Treatment Applications 14.40.2. Research Applications 14.41. Asia Pacific Particle Therapy Market Attractiveness Analysis 14.41.1. By Type 14.41.2. By Product & Services 14.41.3. By System 14.41.4. By Cancer Type 14.41.5. By Application 14.42. PEST Analysis 15. Middle East & Africa Particle Therapy Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Particle Therapy Market Overview 15.3. Middle East & Africa Particle Therapy Market Value Share Analysis, by Type 15.4. Middle East & Africa Particle Therapy Market Forecast, by Type 15.4.1. Proton Therapy 15.4.2. Heavy Ion Therapy 15.5. Middle East & Africa Particle Therapy Market Value Share Analysis, by Product & Services 15.6. Middle East & Africa Particle Therapy Market Forecast, by Product & Services 15.6.1. Cyclotrons 15.6.2. Synchrotrons 15.6.3. Synchrocyclotrons 15.6.4. Others 15.7. Middle East & Africa Particle Therapy Market Value Share Analysis, by System 15.8. Middle East & Africa Particle Therapy Market Forecast, by System 15.8.1. Multi-room Systems 15.8.2. Single-room Systems 15.9. Middle East & Africa Particle Therapy Market Value Share Analysis, by Cancer Type 15.10. Middle East & Africa Particle Therapy Market Forecast, by Cancer Type 15.10.1. Pediatric & Prostate Cancer 15.10.2. Breast Cancer 15.10.3. Lung Cancer 15.10.4. Head & Neck Cancer 15.10.5. Others 15.11. Middle East & Africa Particle Therapy Market Value Share Analysis, by Application 15.12. Middle East & Africa Particle Therapy Market Forecast, by Application 15.12.1. Treatment Applications 15.12.2. Research Applications 15.13. Middle East & Africa Particle Therapy Market Value Share Analysis, by Country 15.14. Middle East & Africa Particle Therapy Market Forecast, by Country 15.14.1. GCC 15.14.2. South Africa 15.14.3. Rest of Middle East & Africa 15.15. Middle East & Africa Particle Therapy Market Analysis, by Country/ Sub-region 15.16. GCC Particle Therapy Market Forecast, by Type 15.16.1. Proton Therapy 15.16.2. Heavy Ion Therapy 15.17. GCC Particle Therapy Market Forecast, by Product & Services 15.17.1. Cyclotrons 15.17.2. Synchrotrons 15.17.3. Synchrocyclotrons 15.17.4. Others 15.18. GCC Particle Therapy Market Forecast, by System 15.18.1. Multi-room Systems 15.18.2. Single-room Systems 15.19. GCC Particle Therapy Market Forecast, by Cancer Type 15.19.1. Pediatric & Prostate Cancer 15.19.2. Breast Cancer 15.19.3. Lung Cancer 15.19.4. Head & Neck Cancer 15.19.5. Others 15.20. GCC Particle Therapy Market Forecast, by Application 15.20.1. Treatment Applications 15.20.2. Research Applications 15.21. South Africa Particle Therapy Market Forecast, by Type 15.21.1. Proton Therapy 15.21.2. Heavy Ion Therapy 15.22. South Africa Particle Therapy Market Forecast, by Product & Services 15.22.1. Cyclotrons 15.22.2. Synchrotrons 15.22.3. Synchrocyclotrons 15.22.4. Others 15.23. South Africa Particle Therapy Market Forecast, by System 15.23.1. Multi-room Systems 15.23.2. Single-room Systems 15.24. South Africa Particle Therapy Market Forecast, by Cancer Type 15.24.1. Pediatric & Prostate Cancer 15.24.2. Breast Cancer 15.24.3. Lung Cancer 15.24.4. Head & Neck Cancer 15.24.5. Others 15.25. South Africa Particle Therapy Market Forecast, by Application 15.25.1. Treatment Applications 15.25.2. Research Applications 15.26. Rest of Middle East & Africa Particle Therapy Market Forecast, by Type 15.26.1. Proton Therapy 15.26.2. Heavy Ion Therapy 15.27. Rest of Middle East & Africa Particle Therapy Market Forecast, by Product & Services 15.27.1. Cyclotrons 15.27.2. Synchrotrons 15.27.3. Synchrocyclotrons 15.27.4. Others 15.28. Rest of Middle East & Africa Particle Therapy Market Forecast, by System 15.28.1. Multi-room Systems 15.28.2. Single-room Systems 15.29. Rest of Middle East & Africa Particle Therapy Market Forecast, by Cancer Type 15.29.1. Pediatric & Prostate Cancer 15.29.2. Breast Cancer 15.29.3. Lung Cancer 15.29.4. Head & Neck Cancer 15.29.5. Others 15.30. Rest of Middle East & Africa Particle Therapy Market Forecast, by Application 15.30.1. Treatment Applications 15.30.2. Research Applications 15.31. Middle East & Africa Particle Therapy Market Attractiveness Analysis 15.31.1. By Type 15.31.2. By Product & Services 15.31.3. By System 15.31.4. By Cancer Type 15.31.5. By Application 15.32. PEST Analysis 16. Latin America Particle Therapy Market Analysis 16.1. Key Findings 16.2. Latin America Particle Therapy Market Overview 16.3. Latin America Particle Therapy Market Value Share Analysis, by Type 16.4. Latin America Particle Therapy Market Forecast, by Type 16.4.1. Proton Therapy 16.4.2. Heavy Ion Therapy 16.5. Latin America Particle Therapy Market Value Share Analysis, by Product & Services 16.6. Latin America Particle Therapy Market Forecast, by Product & Services 16.6.1. Cyclotrons 16.6.2. Synchrotrons 16.6.3. Synchrocyclotrons 16.6.4. Others 16.7. Latin America Particle Therapy Market Value Share Analysis, by System 16.8. Latin America Particle Therapy Market Forecast, by System 16.8.1. Multi-room Systems 16.8.2. Single-room Systems 16.9. Latin America Particle Therapy Market Value Share Analysis, by Cancer Type 16.10. Latin America Particle Therapy Market Forecast, by Cancer Type 16.10.1. Pediatric & Prostate Cancer 16.10.2. Breast Cancer 16.10.3. Lung Cancer 16.10.4. Head & Neck Cancer 16.10.5. Others 16.11. Latin America Particle Therapy Market Value Share Analysis, by Application 16.12. Latin America Particle Therapy Market Forecast, by Application 16.12.1. Treatment Applications 16.12.2. Research Applications 16.13. Latin America Particle Therapy Market Value Share Analysis, by Country 16.14. Latin America Particle Therapy Market Forecast, by Country 16.14.1. Brazil 16.14.2. Mexico 16.14.3. Rest of Latin America 16.15. Latin America Particle Therapy Market Analysis, by Country/ Sub-region 16.16. Brazil Particle Therapy Market Forecast, by Type 16.16.1. Proton Therapy 16.16.2. Heavy Ion Therapy 16.17. Brazil Particle Therapy Market Forecast, by Product & Services 16.17.1. Cyclotrons 16.17.2. Synchrotrons 16.17.3. Synchrocyclotrons 16.17.4. Others 16.18. Brazil Particle Therapy Market Forecast, by System 16.18.1. Multi-room Systems 16.18.2. Single-room Systems 16.19. Brazil Particle Therapy Market Forecast, by Cancer Type 16.19.1. Pediatric & Prostate Cancer 16.19.2. Breast Cancer 16.19.3. Lung Cancer 16.19.4. Head & Neck Cancer 16.19.5. Others 16.20. Brazil Particle Therapy Market Forecast, by Application 16.20.1. Treatment Applications 16.20.2. Research Applications 16.21. Mexico Particle Therapy Market Forecast, by Type 16.21.1. Proton Therapy 16.21.2. Heavy Ion Therapy 16.22. Mexico Particle Therapy Market Forecast, by Product & Services 16.22.1. Cyclotrons 16.22.2. Synchrotrons 16.22.3. Synchrocyclotrons 16.22.4. Others 16.23. Mexico Particle Therapy Market Forecast, by System 16.23.1. Multi-room Systems 16.23.2. Single-room Systems 16.24. Mexico Particle Therapy Market Forecast, by Cancer Type 16.24.1. Pediatric & Prostate Cancer 16.24.2. Breast Cancer 16.24.3. Lung Cancer 16.24.4. Head & Neck Cancer 16.24.5. Others 16.25. Mexico Particle Therapy Market Forecast, by Application 16.25.1. Treatment Applications 16.25.2. Research Applications 16.26. Rest of Latin America Particle Therapy Market Forecast, by Type 16.26.1. Proton Therapy 16.26.2. Heavy Ion Therapy 16.27. Rest of Latin America Particle Therapy Market Forecast, by Product & Services 16.27.1. Cyclotrons 16.27.2. Synchrotrons 16.27.3. Synchrocyclotrons 16.27.4. Others 16.28. Rest of Latin America Particle Therapy Market Forecast, by System 16.28.1. Multi-room Systems 16.28.2. Single-room Systems 16.29. Rest of Latin America Particle Therapy Market Forecast, by Cancer Type 16.29.1. Pediatric & Prostate Cancer 16.29.2. Breast Cancer 16.29.3. Lung Cancer 16.29.4. Head & Neck Cancer 16.29.5. Others 16.30. Rest of Latin America Particle Therapy Market Forecast, by Application 16.30.1. Treatment Applications 16.30.2. Research Applications 16.31. Latin America Particle Therapy Market Attractiveness Analysis 16.31.1. By Type 16.31.2. By Product & Services 16.31.3. By System 16.31.4. By Cancer Type 16.31.5. By Application 16.32. PEST Analysis 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.3. Company Profiles: Key Players 17.3.1. Danfysik A/S 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Business Strategy 17.3.1.4. Recent Developments 17.3.1.5. Manufacturing Footprint 17.3.2. Advanced Oncotherapy PLC. 17.3.3. Hitachi, Ltd. 17.3.4. Ion Beam Applications Sa 17.3.5. Mevion Medical Systems, Inc. 17.3.6. Optivus Proton Therapy, Inc. 17.3.7. Protom International, Inc. 17.3.8. Provision Healthcare, LLC 17.3.9. Sumitomo Heavy Industries, Ltd. 17.3.10. Varian Medical Systems, Inc. 17.3.11. IBA Worldwide 17.3.12. Accuray Incorporated 17.3.13. Brainlab 17.3.14. Elekta AB 17.3.15. Panacea 17.3.16. Shinva Medical Instrument Co. Ltd 17.3.17. Xstrahl 17.3.18. Danfysik A/S 17.3.19. SAH Global LLC 17.3.20. Mitsubishi Electric Corporation 17.3.21. Koninklijke Philips N.V. 17.3.22. PTW Freiburg GmbH 18. Primary Key Insights

About This Report

Report ID 20665
Category Healthcare
Published Date sep 2019
Updated Date Sep 2020
Contact Us